AIMIM chief Asaduddin Owaisi has questioned the efficacy of Covishield, one of many two anti-coronavirus vaccines authorised by the DGCI for emergency use. Owaisi, whereas citing a German authorities report has claimed that, Covishield is efficient for these between 18 and 64 years and it does not work who’re above 64.
“Everybody in the country will have to take coronavirus vaccine be it Covishield or Covaxin. I have one question, the German government said that Covishield, the Oxford-AstraZeneca vaccine which is being manufactured by the Serum Institute of India… the data published on the website of AstraZeneca says that it is good for people between 18 and 64 years. It is not effective on those above 64,” he mentioned.
“It is a coincidence that PM Modi received a Covaxin shot. I want to request the government to clear the confusion,” the Hyderabad MP added and exuded hope that vaccine will attain each nook and nook of the nation.
Covaxin is the second vaccine that has been granted emergency use nod by the DGCI. Covaxin is a completely indigenous vaccine developed by Hyderabad-based Bharat Biotech.